Recovery Of Planters And Expansion In China Will Strengthen Future Prospects

Published
12 Sep 24
Updated
14 Aug 25
AnalystConsensusTarget's Fair Value
US$32.44
10.7% undervalued intrinsic discount
14 Aug
US$28.97
Loading
1Y
-10.2%
7D
2.5%

Author's Valuation

US$32.4

10.7% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on07 May 25
Fair value Increased 1.36%

Shared on30 Apr 25
Fair value Increased 0.094%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on23 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on16 Apr 25
Fair value Increased 1.88%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on09 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on02 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on26 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on19 Mar 25
Fair value Decreased 0.35%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on10 Mar 25
Fair value Decreased 2.54%

AnalystConsensusTarget has increased revenue growth from 1.8% to 2.7%.